针对固体瘤的T细胞免疫疗法:局限性,进展和未来前景
Yinuo Wang1,2, Boyu Zhang3, Yajie Wang4
1College of Life and Environment Science, Huangshan University, Huangshan, Anhui, China.
Frontiers in immunology
|February 16, 2026
概括
对于固体瘤,T细胞免疫疗法显得有前途,克服了瘤微环境抑制等挑战. 在CAR-T,TCR-T和TIL的进步为有效的癌症治疗提供了新的策略.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 包括嵌合式抗原受体 (CAR) T 细胞在内的T 细胞免疫疗法在血液癌症中取得了成功.
- 固体瘤治疗面临障碍:抗原异质性,免疫抑制性瘤微环境 (TME) 和T细胞透/持久性差.
研究的目的:
- 为提供针对固体瘤的T细胞免疫疗法的全面审查.
- 检查CAR-T,TCR-T和TILs的机制,临床进展和挑战.
- 讨论精确免疫治疗的新兴策略和未来前景.
主要方法:
- 对基于T细胞的固体瘤免疫疗法的当前文献的综述.
- 分析CAR-T,TCR-T和TILs的机制,设计原则和临床进展.
- 讨论包括抗原逃逸,非瘤毒性和TME抑制在内的挑战.
主要成果:
- 对于固体瘤的CAR-T,TCR-T和TIL的显著进展被注意到.
- 确定了关键的挑战:抗原逃逸,点外瘤毒性和TME抑制.
- 新兴的策略包括组合准,免疫检查点封锁,合成生物学和基因编辑.
结论:
- 克服生物和技术挑战对于T细胞免疫疗法在固体瘤中的有效性至关重要.
- 精密免疫疗法和多奥米克集成是提高T细胞功能和特异性的关键.
- 需要进一步的研究和临床转化,以优化对固体瘤的T细胞疗法.
更多相关视频
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
1.9K
09:15Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
4.1K
相关概念视频
Tumor Immunotherapy
2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
Cancer Vaccines
1.1K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.1K
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
Cytotoxic T Cells-mediated Immune Response
7.6K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.6K
